The likelihood of severe COVID-19 outcomes among PLHIV with various comorbidities: a comparative frequentist and Bayesian meta-analysis approach.
Haoyi WangKai J JonasPublished in: Journal of the International AIDS Society (2021)
Our meta-analyses show that people with HIV, PLHIV with coexisting diabetes, hypertension, cardiovascular disease, respiratory disease and chronic kidney disease are at a higher likelihood of developing severe COVID-19 outcomes. Bayesian analysis helped to estimate small sample biases and provided predictive likelihoods. Clinical practice should take these risks due to comorbidities into account and not only focus on the HIV status alone, vaccination priorities should be adjusted accordingly.
Keyphrases
- meta analyses
- cardiovascular disease
- systematic review
- coronavirus disease
- antiretroviral therapy
- hiv positive
- sars cov
- hiv testing
- hiv infected
- chronic kidney disease
- human immunodeficiency virus
- clinical practice
- hepatitis c virus
- hiv aids
- type diabetes
- men who have sex with men
- early onset
- randomized controlled trial
- blood pressure
- end stage renal disease
- south africa
- glycemic control
- drug induced
- human health
- peritoneal dialysis
- skeletal muscle
- risk assessment
- cardiovascular risk factors
- metabolic syndrome
- case control